John Alter is currently Vice President, Global Health & Value lead and member of the leadership team of the Global Established Pharma Business Unit at Pfizer. Health & Value functions include Pricing, Market Access, HEOR and Real World Data.
John joined Pfizer in 1998 and has held positions of increasing responsibilities in several functions/divisions including Corporate Finance, Global Manufacturing and Pharmaceutical Commercial Operations in North America, Latin America, Europe, Africa, Middle East and Asia Pacific.
John earned his undergraduate degree from Villanova University and his MBA from George Mason University and served as a U.S. Naval officer for six years before joining industry. He is married with three children.
Raquel has over ten years of experience across a variety of healthcare industry sectors in the US and Europe. Raquel is passionate about working with patients, clinicians, and payers at all stages of product development to address true unmet needs and ensure access.
Prior to joining Ovid, Raquel was Director of Global Market Access at GE Healthcare, based in London. In this role, she led a global team responsible for market access and health economics for new product introductions from the company’s imaging technology portfolio across all therapy areas. At GE Healthcare, Raquel focused on demonstrating the value of innovative technology through research, customer partnerships, digital marketing, and sales support.
Prior to GE, Raquel was a member of Medtronic’s EMEA health economics and reimbursement team, based in Switzerland. Before joining the industry, she was a neuropsychology specialist at Cogstate, a cognitive science start-up, and Columbia University Medical Center where she led operations for federally funded studies that evaluated the specificity of cognitive testing to diagnose Alzheimer’s Disease among minorities.
Raquel earned her MSc in International Health Policy and Health Economics from the London School of Economics and earned her BA in Psychology and French, cum laude, from the University of Pennsylvania. She is also a member of the University of Pennsylvania Fund executive board.